Contact Us
- 0904.634.288, 024.8888.4288
- [email protected]
- Facebook Fanpage: http://fb.com/dauthau.info
- Messenger: http://m.me/dauthau.info
Contact Us
| No | Medicine code | Active ingredient name | Technical criteria group | Concentration or content | How to use | Dosage form | Unit | Quantity | Feature |
|---|---|---|---|---|---|---|---|---|---|
1 |
Ge01 |
HBsAg surface protein (purity> = 95%) |
N5 |
20mcg/1ml |
Intramuscularly |
Injection |
Jar |
375 |
|
2 |
GE02 |
HBsAg surface protein (purity> = 95%) |
N5 |
10mcg/0.5ml |
Intramuscularly |
Injection |
Jar |
50 |
|
3 |
GE03 |
Antigen purified from rabies virus strain L.Pasteur 2061 Vero 15 passage, cultured on vero cells |
N5 |
>=2.5UI/0.5ml |
Intramuscular/injection in the skin |
Dried injection |
Jar |
2.000 |
|
4 |
GE04 |
Refined antigen from Pitman Moore rabies virus |
N5 |
>=2.5UI/0.5ml |
Intramuscular/injection in the skin |
Dried injection |
Jar |
300 |
|
5 |
GE05 |
Detoxification of refined tetanus |
N4 |
>=40UI/0.5ml |
Intramuscular injection |
Injection |
Tube |
450 |
|
6 |
GE06 |
Inactivated, purified Japanese encephalitis virus |
N5 |
6mcg/0.5ml |
Intramuscularly |
Injection |
Jar |
90 |
|
7 |
GE07 |
Inactive antigen A H1N1 A/Guangdong-Maonan/SWL1536/2019 2019 CNIC-1909 (H1N1); Inactive antigen A H3N2 A/Hong Kong/2671/2019 IVR-208 (H3N2); Pure antigen inactivating influenza virus B/Washington/February 2019; Pure antigen inactivation of influenza virus B/Phuket/3073/2013 |
N2 |
(Type A H1N1 - 15mcg; Type A H3N2 - 15mcg; Type B - 15mcg; Type B - 15mcg)/0.5ml |
Intramuscularly |
Injection |
Dose |
100 |
|
8 |
GE08 |
Live, attenuated rotavirus, type G1P[8] |
N4 |
>=2 million PFU/2ml |
Drink |
Oral solution |
Jar |
100 |
|
9 |
GE09 |
Each 0.5ml of vaccine after completion
containing live attenuated varicella virus (Strain: MAV/06, cell line: MRC-5) ≥ 3,800 PFU |
N2 |
≥ 3,800 pfu/0.5 ml |
Subcutaneous |
Dough
dried
inject |
Jar |
100 |
|
10 |
GE10 |
Pure pure outer membrane protein of Group B - 50mcg/0.5ml; Polysaccharide brain bacteria Collection Group C: 50mcg/0.5ml |
N5 |
50mcg/0.5ml |
Intramuscularly |
Injection |
Jar |
100 |
|
11 |
GE11 |
Each single -dose vial: Measles Virus NLT 1000 ccID50; Mumps virus NLT 5000 ccID50; Rubella virus NLT 1000 ccid50 |
N5 |
(≥1,000CCID50 + ≥ 5,000 CCID50 + ≥ 1,000 CCID50)/0.5ml (after reconstitution) |
Injection subcutaneously |
Dried injection |
Jar |
100 |
Select columns to display
If you are still not our member, please sign up.You can use your account on DauThau.info to log in to Dauthau.Net, and vice versa!
Only 5 minutes and absolutely free! Your account can be use on all over our ecosystem, including DauThau.info and DauThau.Net.
Detailed instructions on how to deposit money and redeem points on DauThau.info
When does contract negotiation fail?
[VIDEO] Guide for bid solicitors to Extend the Bid Submission Deadline
[VIDEO] Guide to Evaluating Bid Documents on the New National Bidding Network System
[VIDEO] Guide to Posting Tender Notices for PPP Projects
[VIDEO] Guide to Posting Prequalification Notices for PPP Projects
[VIDEO] Guide to Responding to Clarification Requests for e-HSMST (E-Prequalification Invitation Documents) of PPP Projects on the New National Bidding Network System
[VIDEO] Guide to Uploading the Shortlist for PPP Projects
Similar goods purchased by Investor Trung tâm Y tế thị xã Kiến Tường:
No similar goods purchased by the Investor were found.
Similar goods purchased by other Investor excluding Trung tâm Y tế thị xã Kiến Tường:
No similar goods have been found that other Investor have purchased.
Similar goods for which the bidding results of the Ministry of Health have been announced:
No similar goods have been found in the bidding results of the Ministry of Health.